U.S. Leisure Stock News

NYSE:MFA
NYSE:MFAMortgage REITs

Will MFA’s Q1 Net Loss and Buybacks Reshape MFA Financial's (MFA) Capital Allocation Narrative?

MFA Financial, Inc. reported first-quarter 2026 results showing a net loss of US$984,000 and basic and diluted loss per share of US$0.11 from continuing operations, while also completing a buyback of 500,660 shares for US$5.01 million under its February 18, 2026 repurchase authorization. Management linked the loss to higher rates, wider mortgage spreads, and geopolitical tensions, while simultaneously pursuing expense reduction, portfolio growth and loan resolutions, underscoring a tension...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Why Pagaya Technologies (PGY) Is Up 5.8% After Raising 2026 Outlook And Announcing CFO Transition

Pagaya Technologies reported first-quarter 2026 results with revenue of US$317.94 million and net income of US$24.69 million, raised its full-year 2026 guidance, and announced that Chief Strategy Officer Jonathan Dobres will become Chief Financial Officer on June 15, 2026, while current CFO Evangelos Perros stays on as Strategic Executive Advisor through year-end. The company also signed a new partnership in early May 2026 for Sezzle to embed Pagaya’s AI underwriting platform at checkout,...
NYSE:YUMC
NYSE:YUMCHospitality

A Look At Yum China (YUMC) Valuation After Q1 2026 Results And Ongoing Buybacks

Yum China Holdings (YUMC) has just delivered its first quarter 2026 update, pairing revenue and operating profit growth with fresh details on store expansion, capital returns, and regulatory disclosures that investors can now weigh more closely. See our latest analysis for Yum China Holdings. Despite the first quarter update, Yum China Holdings' share price has moved lower, with a 1 month share price return of 5.75% and a 3 month share price return decline of 17.89%, while the 1 year total...
NYSE:PACS
NYSE:PACSHealthcare

New CFO and Alaska Expansion Might Change The Case For Investing In PACS Group (PACS)

PACS Group, Inc. recently expanded its footprint by acquiring Ridgeway Senior Living in Anchorage, Alaska, along with adjacent land for a planned 150-bed skilled nursing facility, and also set May 11, 2026 as the date it reported its Q1 2026 results. At the same time, the company reshaped its leadership bench by appointing veteran finance executive Carey P. Hendrickson as Chief Financial Officer while co-founder Mark Hancock transitions toward retirement but remains Vice Chairman on the...
NYSE:BBU
NYSE:BBUIndustrials

A Look At Brookfield Business Partners (NYSE:BBU) Valuation After Softer Q1 Earnings And Recent Share Price Pullback

Q1 earnings and dividend decision put Brookfield Business Partners (NYSE:BBU) in focus Brookfield Business Partners (NYSE:BBU) is drawing attention after Brookfield Business Corporation reported first quarter 2026 results with lower sales and net income, alongside a fresh quarterly dividend declaration. For the quarter ended March 31, 2026, Brookfield Business Corporation reported sales of US$6,436 million, compared with US$6,749 million a year earlier, and net income of US$40 million,...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why

In early May 2026, IRADIMED CORPORATION reported first-quarter results showing sales of US$21.98 million and net income of US$5.82 million, alongside board approval of a regular US$0.20 per-share quarterly dividend payable on May 29, 2026 to shareholders of record on May 15, 2026. The company also issued earnings guidance for the second quarter and reaffirmed full-year 2026 revenue and GAAP diluted EPS targets, underscoring management’s confidence in its operating outlook. We’ll now...
NYSE:KRG
NYSE:KRGRetail REITs

What Kite Realty Group Trust (KRG)'s 2026 EPS Guidance After Softer Q1 Results Means For Shareholders

Kite Realty Group Trust reported past first-quarter 2026 results with sales of US$198.04 million and net income of US$11.39 million, alongside lower earnings per share than a year earlier. Alongside these softer year-on-year figures, management issued full-year 2026 earnings guidance of US$0.33 to US$0.39 per diluted share, offering fresh insight into expected profitability. We’ll now examine how this updated 2026 earnings guidance reshapes Kite Realty Group Trust’s existing investment...
NYSE:FUN
NYSE:FUNHospitality

A Look At Six Flags (FUN) Valuation After Strong Q1 Revenue And Attendance Growth

Six Flags Entertainment (FUN) stock recently reacted to first quarter results, as revenue reached US$225.63 million on attendance up 4% and per capita spending up 6%, with net revenue rising 12%. See our latest analysis for Six Flags Entertainment. The Q1 beat on revenue and improving attendance appears to have sparked fresh interest, with the share price up 42.09% year to date and 21.87% over 90 days, although the 1 year total shareholder return is still down 42.28%, pointing to momentum...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

Should Bicara’s Wider Q1 Loss and New Institutional Stakes Shift the BCAX Investment Narrative?

Bicara Therapeutics has reported first-quarter 2026 results showing a wider net loss of US$56.21 million, with basic and diluted loss per share from continuing operations at US$0.93, up from US$0.68 a year earlier. At the same time, institutional investors such as FMR LLC and Red Tree have disclosed mid single-digit percentage stakes, highlighting growing professional interest even as losses increase. We’ll now examine how this larger quarterly loss, against Bicara’s earlier growth...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

Why NewAmsterdam Pharma (NAMS) Is Up 29.7% After Detailing Obicetrapib Phase 3 And Launch Milestones

NewAmsterdam Pharma Company N.V. has reported first-quarter 2026 results, posting US$3.04 million in sales and a net loss of US$48.44 million, while outlining ongoing Phase 3 programs for its lead drug obicetrapib. Investors also heard that an interim analysis of the PREVAIL cardiovascular outcomes trial is planned for late 2026, alongside pending European regulatory decisions and potential initial commercial launches of obicetrapib by Menarini. We will now examine how the planned PREVAIL...
NYSE:IP
NYSE:IPPackaging

International Paper (IP) Is Up 5.9% After Returning To Profitability Amid Margin Pressures Has The Bull Case Changed?

In the past quarter ended March 31, 2026, International Paper reported sales of US$5,971 million, net income of US$60 million, and earnings per share of US$0.11, reversing losses from a year earlier. Despite this return to profitability, management highlighted that margins remain under pressure from inflation, higher energy costs, and transformation-related expenses amid softer packaging demand in key regions. Next, we will examine how International Paper’s return to profitability but...
NYSE:OPLN
NYSE:OPLNCommercial Services

A Look At OPENLANE (OPLN) Valuation After Strong Q1 Results And Upgraded 2026 Earnings Guidance

OPENLANE (OPLN) drew fresh attention after reporting first quarter 2026 results with higher revenue and net income than a year earlier, and raising full year earnings guidance. Analysts responded by increasing their estimates. See our latest analysis for OPENLANE. The raised guidance and stronger first quarter appear to have contributed to momentum, with a 30 day share price return of 27.62% and a year to date share price return of 29.72%. The 3 year total shareholder return of 151.76% points...